Taxus long stent approved
Links shared publicly online about this topic.
- 1,893total visits
Taxus long stent approved
View full resource at theheart.org
Tags: FDA
Most Recently Shared on July 16, 2009 at 10:16 pm By:
heartwire: FDA approves Taxus Liberté "long" stent http://bit.ly/4fs55z
FDA Okays New Drug to Prevent Death, MI - QualityPoint Technologies
qualitypointtech.net — “WASHINGTON (MedPage Today) -- The third time proved to be the charm for the long-awaited new entry into the antiplatelet market as ticagrelor (Brilinta) today won FDA marketing approval for reducing thrombotic events in patients with acute coronary syndrome who are candidates for stenting.” View full resource at qualitypointtech.net
Most Recently Shared on July 21, 2011 at 4:00 am By:
FDA Okays New Drug to Prevent Death, MI: WASHINGTON (MedPage Today) -- The third time proved to be the charm for t... http://bit.ly/mVMlcX
Boston Scientific to sell market-leading stents in India
medcitynews.com — “The Natick, Mass.-based medical device giant said it's launching the third generation of its market-leading Promus and Taxus drug-eluting stents in a country of more than 1.1 billion people. Company officials say the DES market in India is surging, with an estimated 150,000 stents implanted annually. BSX won regulatory approval for the devices in India last year.” View full resource at medcitynews.com
Most Recently Shared on February 17, 2011 at 9:20 pm By:
Boston Scientific to sell market-leading stents in India http://bit.ly/flecNY
Angiotech Announces Long-Term Data Show Advantages For Taxus® Libert® Stent In Small Vessels And Long Lesions
medicalnewstoday.com — “Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) announced that its corporate partner, Boston Scientific Corporation (NYSE: BSX), has released comprehensive data from the TAXUS ATLAS clini” View full resource at medicalnewstoday.com
Most Recently Shared on September 26, 2010 at 12:12 pm By:
Drugs and Devices OW OW Health
Angiotech Announces Long-Term Data Show Advantages For Taxus® Liberté® Stent In Small Vessels And Long ... http://mnt.to/f/3Kn6 #MedDevice
Angiotech Announces Long-Term Data Show Advantages For Taxus Liberté Stent In Small Vessels And Long Lesions - Drugs.com MedNews
drugs.com — “VANCOUVER, Sept. 22 CNW - Angiotech Pharmaceuticals, Inc. (NASDAQ ANPI, TSX ANP) announced that its corporate partner, Boston Scientific Corporation (NYSE BSX),” View full resource at drugs.com
Most Recently Shared on September 23, 2010 at 3:16 pm By:
Drugs and Devices OW OW Health
Angiotech Announces Long-Term Data Show Advantages For Taxus Liberté Stent In Small Vessels And Long Lesions:... http://bit.ly/dsmdb0 #drug
Boston Scientific Announces European Approval Of Platinum Chromium TAXUS(R) Element™ Stent System
medicalnewstoday.com — “Boston Scientific Corporation (NYSE: BSX) announced it has received CE Mark approval for its TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System, the Company's third-generation drug” View full resource at medicalnewstoday.com
Most Recently Shared on May 13, 2010 at 7:40 pm By:
Mona Jauhar Health Professional
MedicalNewsToday: Boston Scientific Announces European Approval Of Platinum Chromium TAXUS(R) Elementâ„¢ Stent System: http://mnt.to/f/3CzH
Boston Scientific Announces European Approval Of Platinum Chromium TAXUS(R) Element(TM) Stent System
medicalnewstoday.com — “Boston Scientific Corporation ( BSX) announced it has received CE Mark approval for its TAXUS(R) Element(TM) Paclitaxel-Eluting Coronary Stent System, the Company's third-generation drug-eluting” View full resource at medicalnewstoday.com
Most Recently Shared on May 13, 2010 at 1:09 pm By:
MNT Pharma News Pharma and Health News
Boston Scientific Announces European Approval Of Platinum Chromium TAXUS(R) Element(TM) Stent System http://mnt.to/3Cy4
Boston Scientific Gets EU Approval for Drug-Coated Stent - WSJ.com
online.wsj.com — “Boston Scientific received European clearance to sell its Taxus Element drug-coated stent, and it will be allowed to be marketed as a treatment for diabetic patients.” View full resource at online.wsj.com
Most Recently Shared on May 12, 2010 at 1:05 pm By:
Boston Scientific Stent Gets EU Approval http://on.wsj.com/bPZzPk
Boston Scientific commences enrollment in its TAXUS Liberte Stent System study
news-medical.net — “Boston Scientific Corporation today announced that it has enrolled the first patient in its TAXUS Liberte post-approval study. The study is designed to evaluate real-world clinical outcomes data for the TAXUS® Liberte® Paclitaxel-Eluting Coronary Stent System in combination with a dual antiplatelet therapy drug regimen that includes aspirin and Effient®, a new antiplatelet medication. Co-sponsors of the study include Eli Lilly and Company and Daiichi Sankyo, Inc., manufacturers of” View full resource at news-medical.net
Most Recently Shared on January 6, 2010 at 2:25 am By:
Stroke News: Boston Scientific commences enrollment in its TAXUS Liberte Stent System study: Boston Scientific Corp... http://bit.ly/8dl41X
Taxus Long Stent Approved
urlborg.com — “: The stent is designed to treat arterial lesions up to 38 mm in length and could potentially reduce the number of stents used in complex cases, according to the company.” View full resource at urlborg.com
Most Recently Shared on July 17, 2009 at 6:52 pm By:
FDA Approves Taxus Liberté "Long" Stent http://ub0.cc/5g/4Q
FDA Approves Boston Scientific's TAXUS(R) Liberte(R) Long Stent
medicalnewstoday.com — “Boston scientific corporation (nyse: bsx) announced it has received approval from the u.s. food and drug administration (fda) to market its taxus((r)) liberte((r)) long paclitaxel-eluting coronar” View full resource at medicalnewstoday.com
Most Recently Shared on July 17, 2009 at 12:16 pm By:
MedicalNewsToday: FDA Approves Boston Scientific's TAXUS(R) Liberte(R) Long Stent http://tinyurl.com/lzkkyz Full http://tinyurl.com/mx96kg
FDA approves Taxus Libert Atom DES
theheart.org — “Heartwire staff and renowned specialists in cardiology from Duke Clinical Research Institute and Mayo Clinic discuss latest developments in interventional surgery.” View full resource at theheart.org
Most Recently Shared on May 29, 2009 at 5:00 pm By:
heartwire: FDA gives go-ahead to second paclitaxel-eluting stent for small-diameter coronaries http://bit.ly/SUDdp
Advertisement
